Latest news with #LovellGovernmentServices
Fox News
23-07-2025
- Business
- Fox News
House hearing examines millions of dollars' worth of improperly documented VA incentive payments
Jen Kiggans, R-Va., led a hearing on Tuesday to discuss millions of dollars' worth of incentive payments distributed by the Department of Veterans Affairs (VA) that were improperly documented. Kiggans, at the House Committee on Veterans' Affairs Subcommittee on Oversight and Investigations hearing, said incentive payments for recruitment, relocation and retention have lacked oversight for years, according to a news release from the House Committee on Veterans' Affairs. "They call it the three Rs, which are recruitment, retention, and relocation," Chris Lovell, a retired Marine Corps Major and CEO of veteran-owned Lovell Government Services, described to Fox News Digital. "It gives additional pay to folks… to keep them and retain them, especially if they have specialty vocations that the VA needs." A recent audit found that between 2020 and 2023, VA payments for relocation grew by 85%, retention payments grew by 131%, and recruitment payments increased by 237%. A total of $1.2 billion worth of incentive payments were given to employees during that period, but $341 million of those were not properly documented, according to the committee. The audit discovered that in one instance, the Veterans Health Administration awarded $30,000 in relocation payments to an employee who never moved, the release noted. Lovell, whose Florida-based business provides resources to the VA, said that this has been an ongoing problem. A 2017 report found improper payments from the VA totaled over $158 million in unsupported spending, according to the release. These documentation issues could be mitigated if the agency improved its management and upgraded its outdated system, Lovell said. The Defense Civilian Pay System, used by both the Department of Defense and the VA, was created more than 30 years ago. "It's a two-pronged approach to cleaning up what's perceived as fraud and waste," he said. "If [management says] they want to clean up erroneous payments or payments without documentation, then they need to supervise that. … And the second piece of that improvement process… is the system." However, Lovell said that the VA is doing "great things" for veterans on a daily basis. "We're happy to be a part of that," he said. In an email, a spokesperson for the VA referred Fox News Digital to the agency's testimony at the hearing. The VA currently has around 482,000 employees, the majority of whom work in the Veterans Health Administration, according to its website. Earlier this year, the Department of Government Efficiency found the VA had paid hundreds of thousands of dollars a month for website changes before canceling the contract and having an internal staffer take over. While combing through loads and loads of data, DOGE discovered a previous contract by the VA for its website maintenance. "Good work by @DeptVetAffairs," DOGE said in a post on X. "VA was previously paying ~$380,000/month for minor website modifications. That contract has not been renewed, and the same work is now being executed by 1 internal VA software engineer spending ~10 hours/week."
Fox News
23-07-2025
- Business
- Fox News
Lovell Government Services CEO reacts to hearing over VA's incentive payments
Chris Lovell, CEO of veteran-owned Lovell Government Services, spoke about the Tuesday hearing that discussed incentive payments given by the Department of Veterans Affairs (VA) with minimal oversight.
Associated Press
04-06-2025
- Business
- Associated Press
Hospital ECAT Win Enables Lovell to Broaden Access to Critical Equipment Across VA and DoD
Lovell Government Services wins ECAT 'This award allows us to rapidly equip federal providers with the reliable tools they need, whether at a VA hospital, DoD facility, or in response to an emergency deployment.'— Chris Lovell, CEO of Lovell Government Services PENSACOLA, FL, UNITED STATES, June 4, 2025 / / -- Lovell Government Services (Lovell), a Service-Disabled Veteran-Owned Small Business (SDVOSB), has been awarded a Hospital ECAT (Electronic Catalog) contract by the Defense Logistics Agency (DLA). The award enhances Lovell's ability to deliver essential medical and surgical equipment to federal health care agencies, including the Department of Veterans Affairs (VA) and Department of Defense (DoD). The award strengthens Lovell's mission to streamline access to patient-ready solutions that support timely, high-quality care for veterans and service members across the country. 'Securing a Hospital ECAT contract is a major step forward in our mission to serve those who serve,' said Chris Lovell, CEO of Lovell Government Services. 'This award allows us to rapidly equip federal providers with the reliable tools they need, whether at a VA hospital, DoD facility, or in response to an emergency deployment.' Through this contract, federal buyers will now have streamlined access to a wide range of equipment and services. The equipment includes, but is not limited to, the following: 1. Hospital Supply Division Equipment: • Examination tables/surgical tables • Hospital beds/chairs/stretchers • Laboratory analyzers • Repair parts for medical equipment • Litters • Sterilizers • Medical refrigerators and other medical storage systems • Ophthalmic equipment • Dental equipment • Medical simulation equipment that is used for training purposes 2. Capital Equipment Division Equipment: • Pulse oximeters • Aspirators • Infusion pumps • Suction apparatus • Resuscitators • Medical lasers • Dental X-Ray systems (Digital) • Robotic surgery systems This development broadens Lovell's role in supporting healthcare providers nationwide, helping to ensure that critical medical equipment is accessible wherever and whenever it is needed most. The ECAT program is a web-based ordering platform managed by the DLA to simplify the acquisition of medical equipment, pharmaceuticals, and supplies for government purchasers. Lovell's award supports federal procurement goals while offering agencies the benefits of SDVOSB contracting and high-quality vendor partnerships. For more information, visit ________________________________________ About Lovell Government Services Lovell Government Services has been a trusted SDVOSB vendor since 2013 with a proven track record of successfully introducing suppliers to the government market. Lovell is a three-time Inc. 5000 honoree and a leader in the federal space. They partner with medical and pharmaceutical companies looking to better serve Veteran and military patient populations, increase their federal revenue stream, and win government contracts. Learn more at Jeff McKay Lovell Government Services +1 850-912-4680 email us here Legal Disclaimer: EIN Presswire provides this news content 'as is' without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
Associated Press
08-04-2025
- Health
- Associated Press
Shiftwave and Lovell Announce Partnership to Increase Access to an Advanced Nervous System Regulation Device for VA, DoD
Shiftwave and Lovell Partner to Bring Advanced Nervous System Regulation Technology to Federal Healthcare Providers 'Through our partnership with Shiftwave, we're bringing veterans a powerful tool to improve their health and recovery, ensuring they get the care they need and deserve.' — Chris Lovell, Major, USMC (Ret.), CEO of Lovell Government Services PENSACOLA, FL, UNITED STATES, April 8, 2025 / / -- Lovell® Government Services and Shiftwave, a leading provider of the Shiftwave System, announced today that they have partnered to serve federal healthcare systems such as the Veterans Health Administration (VHA), the Military Health System (MHS), and the Indian Health Service (IHS). Lovell Government Services will serve as Shiftwave Service-Disabled Veteran-Owned Small Business (SDVOSB) vendor to serve these customers through federal contracting systems. Shiftwave offers a nervous system recovery solution proven especially effective for military personnel, veterans, and first responders who routinely operate under stressful conditions. The portable system combines 18 microprocessor-controlled pulsed pressure wave drivers embedded in a zero-gravity chair with proprietary BioDrive® biofeedback technology. Shiftwave delivers targeted protocols that demonstrate remarkable efficacy in managing chronic pain, sleep disturbances, and stress-related conditions that traditional therapies can struggle to address effectively and as quickly. As Shiftwave SDVOSB Vendor, Lovell is excited to bring this product to federal healthcare providers. Shiftwave is available on the Department of Veterans Affairs' Federal Supply Schedule (FSS), GSA Advantage, and the Defense Logistics Agency's Electronic Catalog (ECAT). Listing products on contract vehicles with Lovell streamlines the acquisition process while helping government agencies meet their SDVOSB procurement goals. 'Through our partnership with Shiftwave, we're bringing veterans a powerful tool to improve their health and recovery, ensuring they get the care they need and deserve.' said Chris Lovell, Major, USMC (Ret.), CEO of Lovell Government Services. 'Shiftwave was originally developed to enhance warfighter performance and resilience within U.S. Special Operations Forces,' said Mike North, Ph.D., Shiftwave CEO & Co-founder. 'Partnering with Lovell Government Services is an exciting step to ensure broader access across the VA and DoD, to provide advanced nervous system regulation technology that profoundly impacts the physical and mental readiness and recovery of those who serve our nation.' About Shiftwave Shiftwave is an innovative neurotechnology company that has emerged as a leader in the field of technology-enhanced nervous system regulation and recovery. The Shiftwave system has been field-tested in clinical settings and humanitarian applications, including Ukrainian military hospitals and rehabilitation centers. Shiftwave is the world's most advanced nervous system regulation device that uses patented BioDrive® and Pulsed Pressure Wave technology to optimize your body's performance, reduce stress, improve focus, enhance sleep, reduce pain and boost overall vitality. Created in a psychophysiology research lab and originally developed for the Special Operating Forces, Shiftwave is an official partner of the NFL Players Association, Exos and OneTeam. It's in use globally, from the NBA to the Premier League, from the Ukrainian frontlines to children's trauma camps, from firefighters to elderly care, and from the boardroom to bedtime for executives. Shiftwave has proven effective in the most challenging of situations, demonstrating that it can benefit anyone. Lovell Government Services has been a trusted SDVOSB vendor since 2013 with a proven track record of successfully introducing suppliers to the government market. Lovell is a three-time Inc. 5000 honoree and leader in the federal space. They partner with medical and pharmaceutical companies looking to better serve Veteran and military patient populations, increase their federal revenue stream, and win government contracts. Learn more at For Media Inquiries: Ryan Camarra Lovell Government Services +1 850-466-3904 Legal Disclaimer:
Associated Press
29-01-2025
- Health
- Associated Press
ONWARD's FDA-Authorized ARC-EX System Restores Hand Strength and Sensation in Spinal Cord Injury Patients
ONWARD's ARC-EX System uses spinal cord stimulation to boost strength and mobility, offering new hope for Veterans and those with spinal cord injuries. 'We're excited to see the ARC-EX System receive FDA authorization. This innovative therapy has the potential to significantly improve strength and mobility for individuals with SCI.' — Chris Lovell, Major, USMC (Ret.), CEO of Lovell Government Services PENSACOLA, FL, UNITED STATES, January 29, 2025 / / -- ONWARD's Medical's recently FDA-authorized ARC-EX System delivers targeted, programmed stimulation of the spinal cord to restore upper extremity strength and function in people with spinal cord injuries. This first-of-its-kind therapy represents a significant advancement in the treatment options available to veterans and others living with a Spinal Cord Injury (SCI). The ARC-EX System delivers targeted, programmed stimulation of the spinal cord to restore hand strength and sensation in people with SCI. This first-of-its-kind therapy represents a significant advancement in the treatment options available to Veterans and others living with SCI. It was authorized for commercial sale in the US by the FDA in December 2024. 'Adding the ARC-EX System to two major US federal government purchasing platforms is an important step toward making our therapy broadly available to US military Veterans living with spinal cord injury,' said Dave Marver, CEO, ONWARD Medical. 'The VA serves a significant percentage of Americans with spinal cord injury, and establishing these procurement channels soon after FDA authorization demonstrates our commitment to ensuring federal healthcare providers have rapid access to the latest technology.' For questions about the ARC-EX System and its availability in the United States, visit this webform. To learn more about ONWARD Medical's commitment to partnering with the SCI Community to develop innovative solutions for restoring movement, function, and independence after spinal cord injury, please visit 'We're excited to see the ARC-EX System receive FDA authorization. This innovative therapy has the potential to significantly improve strength and mobility for individuals with SCI.' said Chris Lovell, Major, USMC (Ret.), CEO of Lovell Government Services. About Lovell Government Services Lovell Government Services has been a trusted SDVOSB vendor since 2013 with a proven track record of successfully introducing suppliers to the government market. Lovell is a three-time Inc. 5000 honoree and leader in the federal space. They partner with medical and pharmaceutical companies looking to better serve Veteran and military patient populations, increase their federal revenue stream, and win government contracts. For more information, visit About ONWARD Medical ONWARD Medical is a medical technology company creating therapies to restore movement, function, and independence in people with SCI and other movement disabilities. Building on more than a decade of scientific discovery, preclinical research, and clinical studies conducted at leading hospitals, rehabilitation clinics, and neuroscience laboratories, the Company has developed ARC Therapy, which has been awarded ten Breakthrough Device Designations from the US Food and Drug Administration (FDA). The Company's ARC-EX System is now cleared for commercial sale in the US. In addition, the Company is developing an investigational implantable system called ARC-IM with and without an implanted brain-computer interface (BCI). Headquartered in the Netherlands, the Company has a Science and Engineering Center in Switzerland and a US office in Boston, Massachusetts. The Company is listed on Euronext Paris, Brussels, and Amsterdam (ticker: ONWD). For more information, visit and connect with us on LinkedIn and YouTube. For Investor Inquiries: Disclaimer Certain statements, beliefs, and opinions in this press release are forward-looking, which reflect the Company's or, as appropriate, the Company directors' current expectations and projections about future events. By their nature, forward-looking statements involve several risks, uncertainties, and assumptions that could cause actual results or events to differ materially from those expressed or implied by the forward-looking statements. These risks, uncertainties, and assumptions could adversely affect the outcome and financial effects of the plans and events described herein. A multitude of factors including, but not limited to, delays in regulatory approvals, changes in demand, competition, and technology, can cause actual events, performance, or results to differ significantly from any anticipated development. Forward-looking statements contained in this press release regarding past trends or activities should not be taken as a representation that such trends or activities will continue in the future. As a result, the Company expressly disclaims any obligation or undertaking to release any update or revisions to any forward-looking statements in this press release as a result of any change in expectations or any change in events, conditions, assumptions, or circumstances on which these forward-looking statements are based. Neither the Company nor its advisers or representatives nor any of its subsidiary undertakings or any such person's officers or employees guarantees that the assumptions underlying such forward-looking statements are free from errors nor does either accept any responsibility for the future accuracy of the forward-looking statements contained in this press release or the actual occurrence of the forecasted developments. You should not place undue reliance on forward-looking statements, which speak only as of the date of this press release. ARC-EX Indication for Use (US): The ARC-EX System is intended to deliver programmed, transcutaneous electrical spinal cord stimulation in conjunction with functional task practice in the clinic to improve hand sensation and strength in individuals between 18 and 75 years old that present with a chronic, non-progressive neurological deficit resulting from an incomplete spinal cord injury (C2-C8 inclusive). Other Investigational Products: All other ONWARD Medical devices and therapies including ARC-IM and ARC-BCI are investigational and not available for commercial use. Trademarks: ONWARD, ARC-EX, ARC-IM, ARC-BCI, and the stylized O-Logo are proprietary and registered trademarks of ONWARD Medical. Unauthorized use is strictly prohibited. For Media Inquiries: Ryan Camarra Lovell Government Services
